Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Plain PLGA particles can be used for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.A study reports the use of PLGA nanoparticles as estrogen carriers. The carrier-drug system was prepared by emulsification-diffusion method.

General description

The particle size of the PLGA nanoparticles are closely dependent on both the nature and concentration of the stabilizer and polymer.

Degradex^® is made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a Mw of 30,000.To re-constitute: Remove the product from freezer. Wait until temperature rises to the ambient temperature. Add DI water or buffer to the container. Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.

Legal Information

Degradex is a registered trademark of Phosphorex, Inc.

Packaging

50 mg in poly bottle